| USD millions | FY2024 | FY2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Research & development | 78.0 | 81.4 |
| Selling, general & administrative | 25.0 | 42.1 |
| Selling & marketing | 0.0 | 0.0 |
| Operating expenses | 103.2 | 123.5 |
| Operating income | (103.2) | (123.5) |
| Interest expense | 0.0 | 0.0 |
| Interest income | 0.0 | 0.0 |
| Other income / expense | 7.3 | 4.7 |
| Pre-tax income | (95.9) | (118.8) |
| Income tax | 0.0 | 0.0 |
| Net income | (95.9) | (118.8) |
| Discontinued operations | 0.0 | 0.0 |
| Other net income adjustments | 0.0 | 0.0 |
| EPS, basic (per share) | (0.48) | (0.53) |
| EPS, diluted (per share) | (0.48) | (0.53) |
| EBITDA | (103.1) | (123.5) |
| Depreciation & amortization | 0.1 | 0.1 |
| Weighted average shares (shares) | 198,191,936 | 222,387,531 |
| Weighted average diluted shares (shares) | 198,191,936 | 222,387,531 |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.